UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000014269
Receipt number R000016583
Scientific Title Concurrent use of Sr-89 chloride with bone-modifying agent(denosumab, zoledronic acid) is safe and effective for breast cancer patients with painful bone metastases
Date of disclosure of the study information 2014/06/19
Last modified on 2017/12/19 11:27:52

No. Disposal Last modified on Item of update
1 Insert 2014/06/15 16:27:42
2 Update 2015/08/11 15:41:44 UMIN ID1
3 Update 2017/12/19 11:27:52 Recruitment status